Market Research Life Sciences Market Research Diagnostics Market Research In Vitro Diagnostics Market Research Microbiology & Virology Market Research

Lyme Disease Diagnostics Market (Diagnostic Test: Serological Test, Polymerase Chain Reaction [PCR] Test, and Others; and Sample: Blood, Cerebrospinal Fluid [CSF], and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-203

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 180 Pages Transparency Market Research Pvt. Ltd. August, 2023 TNPR18249851
Best Price Guarantee
Price from $5,795
Length 180 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date August, 2023
SKU TNPR18249851

Lyme Disease Diagnostics Market (Diagnostic Test: Serological Test, Polymerase Chain Reaction [PCR] Test, and Others; and Sample: Blood, Cerebrospinal Fluid [CSF], and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Lyme Disease Diagnostics Market – Scope of Report

TMR’s report on the global lyme disease diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global lyme disease diagnostics market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global lyme disease diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the lyme disease diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global lyme disease diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global lyme disease diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global lyme disease diagnostics market.

The report delves into the competitive landscape of the global lyme disease diagnostics market. Key players operating in the global lyme disease diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global lyme disease diagnostics market profiled in this report.

Key Questions Answered in Global Lyme Disease Diagnostics Market Report
  • What is the sales/revenue generated by lyme disease diagnostics across all regions during the forecast period?
  • What are the opportunities in the global lyme disease diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Lyme Disease Diagnostics Market – Research Objectives and Research Approach

The comprehensive report on the global lyme disease diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global lyme disease diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global lyme disease diagnostics market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Lyme Disease Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Lyme Disease Diagnostics Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projection (US$ Mn)
5. Key Insights
5.1. Innovations in Diagnostic Testing for Lyme disease
5.2. Incidence and Prevalence of Lyme Disease
5.3. Regulatory Scenario by Region/Globally
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)
6. Global Lyme Disease Diagnostics Market Analysis and Forecast, by Diagnostic Test
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Diagnostic Test, 2017-2031
6.3.1. Serological Test
6.3.1.1. ELISA
6.3.1.2. Western Blot
6.3.2. Polymerase Chain Reaction (PCR) test
6.3.3. Others
6.4. Market Attractiveness Analysis, by Diagnostic Test
7. Global Lyme Disease Diagnostics Market Analysis and Forecast, by Sample
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Sample, 2017-2031
7.3.1. Blood
7.3.2. Cerebrospinal Fluid (CSF)
7.3.3. Others
7.4. Market Attractiveness Analysis, by Sample
8. Global Lyme Disease Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Lyme Disease Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Lyme Disease Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Diagnostic Test, 2017-2031
10.2.1. Serological Test
10.2.1.1. ELISA
10.2.1.2. Western Blot
10.2.2. Polymerase Chain Reaction (PCR) test
10.2.3. Others
10.3. Market Value Forecast, by Sample, 2017-2031
10.3.1. Blood
10.3.2. Cerebrospinal Fluid (CSF)
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Diagnostic Test
10.6.2. By Sample
10.6.3. By End-user
10.6.4. By Country
11. Europe Lyme Disease Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Diagnostic Test, 2017-2031
11.2.1. Serological Test
11.2.1.1. ELISA
11.2.1.2. Western Blot
11.2.2. Polymerase Chain Reaction (PCR) test
11.2.3. Others
11.3. Market Value Forecast, by Sample, 2017-2031
11.3.1. Blood
11.3.2. Cerebrospinal Fluid (CSF)
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Diagnostic Test
11.6.2. By Sample
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Lyme Disease Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Diagnostic Test, 2017-2031
12.2.1. Serological Test
12.2.1.1. ELISA
12.2.1.2. Western Blot
12.2.2. Polymerase Chain Reaction (PCR) test
12.2.3. Others
12.3. Market Value Forecast, by Sample, 2017-2031
12.3.1. Blood
12.3.2. Cerebrospinal Fluid (CSF)
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Diagnostic Test
12.6.2. By Sample
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Lyme Disease Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Diagnostic Test, 2017-2031
13.2.1. Serological Test
13.2.1.1. ELISA
13.2.1.2. Western Blot
13.2.2. Polymerase Chain Reaction (PCR) test
13.2.3. Others
13.3. Market Value Forecast, by Sample, 2017-2031
13.3.1. Blood
13.3.2. Cerebrospinal Fluid (CSF)
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Diagnostic Test
13.6.2. By Sample
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Lyme Disease Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Diagnostic Test, 2017-2031
14.2.1. Serological Test
14.2.1.1. ELISA
14.2.1.2. Western Blot
14.2.2. Polymerase Chain Reaction (PCR) test
14.2.3. Others
14.3. Market Value Forecast, by Sample, 2017-2031
14.3.1. Blood
14.3.2. Cerebrospinal Fluid (CSF)
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Diagnostic Test
14.6.2. By Sample
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. LabCorp
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Quest Diagnostics
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Abbott Laboratories
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Bio-Rad Laboratories, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. bioMérieux SA
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. DiaSorin S.p.A.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. T2 Biosystems, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. F. Hoffmann-La Roche AG
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Meridian Bioscience, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Quidel Corporation
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings